The effects of the new antiarrhythmic E 047/1 on postoperative ischemia- induced arrhythmias in dogs

Anesthesia and Analgesia

Volumn 89, Issue 6, 1999, Pages 1393-1399

  Kulier, Alexander H ^a,b   Novalija, Enis ^a   Hogan, Quinn ^a   Vicenzi, Martin N ^a   Woehlck, Harvey J ^a   Bajic, Jurica ^a   Atlee III, John L ^a   Bosnjak, Zeljko J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BUTYL 3 BENZOFURANYL) 1 [5 [2 (DIETHYLAMINO)ETHOXY] 2 THIENYL]METHANONE; AMIODARONE; ANTIARRHYTHMIC AGENT; BENZOFURAN; BRETYLIUM; FLECAINIDE; LIDOCAINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0032747218     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-199912000-00012     Document Type: Article

References (28)

1. Pires LA, Wagshal AB, Lancey R, Huang SK. Arrhythmias and conduction disturbances after coronary artery bypass graft surgery: epidemiology, management, and prognosis. Am Heart J 1995;129:799-808.
2. Davis RF. Etiology and treatment of perioperative cardiac arrhythmias. In: Kaplan JA, ed. Cardiac anesthesia. 3rd ed. Philadelphia: WB Saunders, 1993:170-205.
3. Willems S, Weiss C, Meinertz T. Tachyarrhythmias following coronary artery bypass graft surgery: epidemiology, mechanisms, and current therapeutic strategies. Thorac Cardiovasc Surg 1997;45:232-7.
4. Smith RC, Leung JM, Mangano DT. Postoperative myocardial ischemia in patients undergoing coronary artery bypass graft surgery. Anesthesiology 1991;74:464-73.
5. Binah O, Rosen MR. Mechanisms of ventricular arrhythmias. Circulation 1992;85:125-31.
6. Dewar ML, Rosengarten MD, Blundell PE, Chiu RC. Perioperative Holter monitoring and computer analysis of dysrhythmias in cardiac surgery. Chest 1985;87:593-7.
7. Kulier AH, Novalija E, Rakic M, et al. Suppression of postinfarct ventricular dysrhythmias does not prevent sudden cardiac death in conscious dogs [abstract]. Anesthesiology 1996;85: A619.
8. Kowey PR, Marinchak RA, Rials SJ, Filart RA. Intravenous amiodarone. J Am Coll Cardiol 1997;29:1190-8.
9. Ryan T, Anderson J, Antman E, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary - report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1996;94:2341-50.
10. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324: 781-8.
11. Woehlck HJ, Kulier AH, Vicenzi MN, et al. E 047/1: antidysrhythmic efficacy and blood pressure of three different forms of administration [abstract]. FASEB J 1995;9:A 603/3494.
12. Kulier AH, Novalija E, Vicenzi MN, et al. Antidysrhythmic effects of E 047/1 compared to lidocaine, bretylium, amiodarone and flecainide in dogs with post-infarction dysrhythmias (abstract). Anesthesiology 1995;V83:A639.
13. Gombotz H, Mahla E, Vicenzi M, et al. E 047/1, a new amiodarone-derivative in postoperative dysrhythmias. A phase II study (abstract). Anesthesiology 1997;87:A133.
14. Bosnjak ZJ, Turner LA, Contney SJ, Kulier A. Electrophysiologic effects of E 047/1 on Purkinje fibers from normal and infarcted canine hearts (abstract). FASEB J 1995;9:A602/3492.
15. Wit AL, Janse MJ. Delayed ventricular arrhythmias in the sub-acute phase of myocardial infarction. In: Wit AL, Janse MJ, Eds. The ventricular arrhythmias of ischemia and infarction. Mount Kisco: Futura, 1993;267-356.
16. Wit AL, Janse MJ. Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction. Circulation 1992;85:132-42.
17. Gough WB, Zeiler RH, Barreca P, El-Sherif N. Hypotensive action of commercial intravenous amiodarone and polysorbate 80 in dogs. J Cardiovasc Pharmacol 1982;4:375-80.
18. King FG, Addetia AM, Peters SD, Peachey GO. Prophylactic lidocaine for postoperative coronary artery bypass patients, a double-blind, randomized trial. Canadian Journal of Anaesthesia Journal Canadien d Anesthesie 1990;37:363-8.
19. Aberg G, Ronfeld R, Aberg L, et al. Antiarrhythmic effects of tocainide and lidocaine in dogs. Acta Pharmacol Toxicol 1983; 53:146-52.
20. Nattel S, Davies M, Quantz M. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction. Circulation 1988; 77:200-8.
21. Hashimoto H, Katoh H, Nakashima M. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction. J Pharmacobiodyn 1992;15:191-201.
22. Fujimoto T, Hamamoto H, Peter T, et al. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion. Am Heart J 1983;105:966-72.
23. Davis J, Glassman R, Wit AL. Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardias with different electrophysiologic characteristics and different mechanisms in the infarcted canine heart. Am J Cardiol 1982;49:1176-84.
24. Lazzara R, el-Sherif N, Scherlag BJ. Electrophysiological properties of canine Purkinje cells in one-day-old myocardial infarction. Circ Res 1973;33:722-34.
25. Northover BJ. Ventricular tachycardia during the first 72 hours after acute myocardial infarction. Cardiology 1982;69:149-56.
26. Campbell RW, Murray A, Julian DG. Ventricular arrhythmias in first 12 hours of acute myocardial infarction. Natural history study. Br Heart J 1981;46:351-7.
27. Lynch J, Jr., Heaney LA, Wallace AA, et al. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction. J Cardiovasc Pharmacol 1990;16:41-9.
28. Anderson JL. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Clin Ther 1985;7:205-24.